GRIFOLS USA Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • GRIFOLS USA's estimated annual revenue is currently $5.2B per year.(i)
  • GRIFOLS USA's estimated revenue per employee is $5,922,551
  • GRIFOLS USA's current valuation is $12.2B. (January 2022)

Employee Data

  • GRIFOLS USA has 878 Employees.(i)
  • GRIFOLS USA grew their employee count by 19% last year.

GRIFOLS USA's People

NameTitleEmail/Phone
1
Senior Director OperationsReveal Email/Phone
2
Regional Director, Business DevelopmentReveal Email/Phone
3
Associate Director Sales Performance ManagementReveal Email/Phone
4
National Sales DirectorReveal Email/Phone
5
Director, Head North America Customer MarketingReveal Email/Phone
6
Regional Sales Manager - SEReveal Email/Phone
7
Center Quality ManagerReveal Email/Phone
8
Facility Project ManagerReveal Email/Phone
9
Quality Systems ManagerReveal Email/Phone
10
Center ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M7920%N/AN/A
#2
$8.5M3111%N/AN/A
#3
$4.5M13-13%N/AN/A
#4
$8M25-4%N/AN/A
#5
$5.3M16-6%N/AN/A
#6
$54.2M163-8%N/AN/A
#7
$12M55-17%$63.2MN/A
#8
$10M30-9%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M43-7%N/AN/A
Add Company

What Is GRIFOLS USA?

Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. We accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care. We have three primary divisions -- Bioscience, Diagnostic and Hospital – which develop, produce and market our innovative products and services to medical professionals in more than 90 countries around the world.

keywords:N/A

N/A

Total Funding

878

Number of Employees

$5.2B

Revenue (est)

19%

Employee Growth %

$12.2B

Valuation

N/A

Accelerator

GRIFOLS USA News

2022-04-20 - POC and IVD Market: Everything You Need to Know ...

... to Know | DiaSorin S.p.A,Grifols S.A, Becton Dickinson and Company ... Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

2022-04-17 - Lyophilized Ivig Market Size 2022 Analysis By Top Keyplayers ...

... Size 2022 Analysis By Top Keyplayers | Baxter, Grifols, Csl, Octapharma ... New Jersey, USA,- The global Lyophilized Ivig Market is...

2022-04-17 - Fibrin Sealant Human Market Size 2022 Analysis By Top ...

... Size 2022 Analysis By Top Keyplayers | Baxter, Csl, Bayer, Grifols ... New Jersey, USA,- The global Fibrin Sealant Human Market is...

2021-11-24 - Grifols S A : launches new home-care treatment service for patients with alpha-1 antitrypsin deficiency in Spain

November 24, 2021 Grifols launches new home-care treatment service for patients with alpha-1 antitrypsin deficiency in Spain Print this news Download the press release The new service will include the administration of the intravenous treatments in patients' homes by a healthcare professional, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$300M879-12%N/A
#2
$220.4M88429%$137M
#3
$344M88715%N/A
#4
$35M88713%N/A
#5
$12240M8884%N/A